A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in the Netherlands

Expert Review of Anticancer Therapy

Volumn 15, Issue 2, 2015, Pages 157-164

  Van Zanten, Sophie E M Veldhuijzen ^a,b   Jansen, Marc Ha ^a,b   Sanchez Aliaga, Esther ^a   Van Vuurden, Dannis G ^a,b   Vandertop, W Peter ^a   Kaspers, Gertjan Jl ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b University of Amsterdam   (Netherlands)

Author keywords

brainstem tumor; chemotherapy; clinical trial; diffuse intrinsic pontine glioma; high grade glioma; pediatric oncology; radiotherapy; treatment

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; ERLOTINIB; LOMUSTINE; METHOTREXATE; PROCARBAZINE; TEMOZOLOMIDE; THALIDOMIDE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE DURATION; HUMAN; NETHERLANDS; PALLIATIVE THERAPY; PATIENT CARE; PHYSICAL EXAMINATION; PONTINE GLIOMA; POPULATION RESEARCH; PREVALENCE; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; BRAIN STEM NEOPLASMS; CHILD; FEMALE; GLIOMA; MALE; PATHOLOGY; PONS; PRESCHOOL CHILD; PROGNOSIS; SURVIVAL RATE;

BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GLIOMA; HUMANS; MALE; NETHERLANDS; PONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84921462483     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2015.974563     Document Type: Review

References (26)

1. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 2006;7:241-8
2. Berger MS, Edwards MS, LaMasters D, et al. Pediatric brain stem tumors: radiographic, pathological, and clinical correlations. Neurosurgery 1983;12:298-302
3. Epstein F. A staging system for brain stem gliomas. Cancer 1985;56:1804-6
4. Stroink AR, Hoffman HJ, Hendrick EB, et al. Diagnosis and management of pediatric brain-stem gliomas. JNS 1986;65:745-50
5. Barkovich AJ, Krischer J, Kun LE, et al. Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 1990;16:73-83
6. Bartels U, Hawkins C, Vezina G, et al. Proceedings of the diffuse intrinsic pontine glioma (DIPG) Toronto Think Tank: advancing basic and translational research and cooperation. J Neurooncol 2011;105: 119-25
7. Jansen MH, van Vuurden DG, Vandertop WP, et al. Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology. Cancer Treat Rev 2012;38:27-35
8. Grimm SA, Chamberlain MC. Brainstem glioma: a Review. Curr Neurol Neurosci Rep 2013;13:346
9. Schild SE, Stafford SL, Brown PD, et al. The results of radiotherapy for brainstem tumors. J Neurooncol 1998;40:171-7
10. Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma. Available from: http://clinicaltrials.gov/show/NCT00028795
11. Cohen KJ, Heideman RL, Zhou T, et al. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontinegliomas: a report from the Children's Oncology Group. Neuro Oncol 2011;13:410-16
12. Temozolomide in children with recurrent or refractory CNS tumors. Available from: http://www. trialregister. nl/trialreg/admin/ rctview. asp?TC=227
13. Combination therapy for children with malignant pontine gliomas. Available from: http://www. trialregister. nl/trialreg/admin/ rctview. asp?TC=2391
14. Tonn JC. Neuro-Oncology of CNS Tumors. Heidelberg: Springer, 2006
15. Knops RR, van Dalen EC, Mulder RL, et al. The volume effect in pediatric oncology: a systematic review. Ann Oncol 2013;24:1749-53
16. Caretti V, Jansen MH, van Vuurden DG, et al. Implementation of a Multi-Institutional Diffuse Intrinsic Pontine Glioma Autopsy Protocol and Characterization of a Primary Cell Culture. Neuropathol Appl Neurobiol 2013;39: 426-36
17. Wu G, Broniscer A, McEachron TA, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nature Genetics 2012;44(3):251-3
18. Khuong-Quang D-A, Buczkowicz P, Rakopoulos P, et al. K27M mutation in histone H3. 3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 2012;124:439-47
19. Puget S, Philippe C, Bax DA, et al. Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 2012; 7(2):e30313
20. Jansen MH, Veldhuijzen van Zanten SEM, van Vuurden DG, et al. Molecular Drug Imaging: Pioneering Work in Children with Brain Cancer. Submit to J Nucl Med 2014
21. Broniscer A, Laningham F, Sanders R, et al. Young Age May Predict a Better Outcome for Children With Diffuse Pontine Glioma. Cancer 2008;113:566-72
22. Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, et al. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 2014
23. Bailey S, Howman A, Wheatley K, et al. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy-Results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer 2013;49(18): 3856-62
24. Jackson S, Patay Z, Howarth R, et al. Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontineglioma. J Neurooncol 2013;114: 339-44
25. DIPG Registry. Available from: http://www. dipgregistry. eu
26. DIPG. Available from: http://www. dipgregistry. org/